Dr. Anil Kumar (PhD)
Head of CMC in Europe, ACROBiosystems
At ACROBiosystems, Dr. Anil Kumar spearheads the team's initiatives of raising awareness and promoting advanced GMP grade solutions for clinical manufacturing of cell and gene therapies. With a PhD in Protein Engineering and over a decade of experience in biopharmaceutical research and development, Anil has been instrumental in leading teams and advancing therapeutic modalities for immune-oncology and auto-immune indications. Prior to joining ACROBiosystems, Anil served as the Director of Antibody Discovery and Protein Engineering at ImmunOs Therapeutics AG. During his tenure, his team played a pivotal role in advancing therapeutic modalities targeting solid tumors, notably placing the lead biologic candidate IOS-1002 for clinical development.
STREAMLINING CELL THERAPY MANUFACTURING WITH ACROBIOSYSTEMS AS YOUR GMP RAW MATERIAL SUPPLIER
Thursday, July 11, 2024
5:00 PM – 5:15 PM CEST